logo
Plus   Neg
Share
Email

Clearwater Paper Names Johnathan Hunter Interim CFO

Clearwater Paper Corp. (CLW), which manufactures and sells pulp-based products, disclosed on Friday that it has elected Johnathan Hunter as its Interim Chief Financial Officer, effective April 13, 2012. Hunter has assumed the duties and responsibilities of CFO from Linda Massman.

Massman, who has been chief financial officer since the company's spin-off from Potlatch Corporation in December 2008, will remain as President and Chief Operating Officer.

Clearwater Paper said it is currently engaged in a search for a permanent financial chief and that Hunter will serve in the interim role, until a permanent CFO is in place. Hunter will continue in his role as Vice President, Corporate Controller and is based at the company's Spokane headquarters.

Hunter served as Corporate Controller of the company from August 2009 to December 2011, and as Vice President, Corporate Controller since December 2011.

The company's stock closed Friday's trading session at $31.03.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT